Related Experiment Video
Updated: Jan 19, 2026

Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
Published on: January 31, 2025
Functional outcome in extremity soft tissue sarcoma
1Departments of Physical Therapy and Surgery, Mount Sinai Hospital, Toronto, Canada.
Abstract:
The studies reporting functional outcome for patients undergoing limb preservation surgery for extremity soft tissue sarcoma (STS) have evaluated mainly impairments, that is, deficits at an anatomic structure level, such as joint range of motion and strength. Disability, activities of daily living, self-care, and mobility have been less frequently evaluated. Review of the literature suggests that approximately 50% of patients treated for STS have significant impairments, whereas the frequency of disability is less. Synthesis of the results is difficult because of the heterogeneity of patient samples, treatment, and the outcomes used to evaluate function. Future studies require the use of standardized definitions and reliable and valid functional outcome measures. Improved patient outcomes can be achieved only by understanding the determinants of these outcomes and by introducing interventions to improve patient functional outcome.
Related Concept Videos
09:38Minimally Invasive Isolated Limb Perfusion (MI-ILP) for Locally Advanced Melanomas and Sarcomas of the Extremity
07:15A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
07:55Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
11:42Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
12:44The In ovo CAM-assay as a Xenograft Model for Sarcoma
07:49Isolating Stem Cells from Soft Musculoskeletal Tissues

